Clinical Trial, 2021-2022

over 400 Lesions, 2021-2022 

IMG_9648.JPG

PatScope Scanner (Beta)

PatScope

Dermoscopy

Cancer

Vs

Benign

Example_CvsB_edited.jpg

Cancer

2021.5.2_GSPI_H9.jpg

Benign

Versus

2021.5.2_GSPI_H10.jpg

Protocol

The scans were performed on lesions found by a board-certified dermatologist that was about to be biopsied. The patient consented and the scan was performed. 

 

We expect that lesions with atypia will have prominent lateral movement of the backscattered light (LMB) with no random patterns. 

 

In non-atypical lesions, we expect a random LMB. To confirm our suspicions the scans were correlated with histology.

 

To be able to monitor in-between distortion situations we scanned two tissue conditions

  1. Atypic: MM, SCC,BCC

  2. Not Atypic: SK, ISK, DN

Biopsy  consent

We may possibly scan the lesions with the Patternox scope (PatScope); these scans will be used for research and possibly publication.  The PatScope is a non-invasive visible light to examine the backscattered light produced from the scan of the skin. There will be no identifiable data released to a third party.